Acne Vulgaris
📧 Sign up to get email alerts when something new happens for Acne Vulgaris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-11-02FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Claravis (isotretinoin). This document announces the approval of a supplemental submission …
-
FDA approval · 2007-11-02FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals Inc.
-
FDA approval · 2007-11-02FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for CLARAVIS (isotretinoin) submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels. [Phase 4]
Phase 4 pilot, multi-center study comparing two clindamycin/benzoyl peroxide gel formulations for acne vulgaris has completed.
-
FDA approval · 2007-09-05FDA Approved: DIFFERIN — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for DIFFERIN (adapalene) from Galderma Laboratories, L.P.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-07-26FDA Approved: TRETINOIN — Original Application (Obagi Cosmeceuticals LLC)
FDA approves Obagi Cosmeceuticals LLC's original application for a topical tretinoin product. This approval supports its use for acne vulgar…
-
FDA approval · 2007-06-19FDA Approved: ADAPALENE — Original Application (Mayne Pharma Commercial LLC.)
FDA approval of Adapalene from Mayne Pharma Commercial LLC (Original Application) for topical use.
-
FDA approval · 2007-04-20FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for tretinoin from Padagis US LLC, authorizing changes to the labeling under the ANDA for this p…
-
FDA label_change · 2007-04-20FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for tretinoin from Padagis US LLC, resulting in updated labeling.
-
FDA approval · 2007-04-20FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for tretinoin submitted by Padagis US LLC.
-
FDA approval · 2007-02-21FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for tretinoin from Padagis US LLC, indicating an update to an existing product's labeling or man…
-
FDA approval · 2007-02-21FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for tretinoin from Padagis US LLC, confirming the approval of the generic product and related la…
-
FDA approval · 2007-02-21FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for tretinoin by Padagis US LLC, authorizing changes to the approved generic product.
-
FDA approval · 2007-02-21FDA Approved: TRETINOIN — Supplemental Application (Padagis US LLC)
The FDA approved a supplemental application for tretinoin submitted by Padagis US LLC, authorizing changes to the product's labeling under A…
-
CLINICAL_TRIALS research · 2007-02-07Clinical Trial Update: Study of Oral Zileuton in the Treatment of Moderate to Severe Facial Acne Vulgaris [Phase 2]
This document reports a Phase 2 clinical trial evaluating oral zileuton for moderate to severe facial acne vulgaris; the study status is cur…
-
FDA label_change · 2007-02-06FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Amnesteem (isotretinoin) from Mylan Pharmaceuticals, related to the generic product's labeli…
-
FDA approval · 2007-02-02FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Claravis (isotretinoin) filed by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2007-02-02FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for CLARAVIS (isotretinoin) from Teva, updating its labeling.
-
FDA approval · 2006-11-07FDA Approved: ZIANA — Original Application (Bausch Health US, LLC)
FDA approved ZIANA (clindamycin phosphate and tretinoin) through an original application for the treatment of acne vulgaris. This marks the …
-
CLINICAL_TRIALS trial_result · 2006-10-11Clinical Trial Update: Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study [NA]
A randomized blinded controlled study evaluating photodynamic therapy for acne vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-08Clinical Trial Update: Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessed the efficacy and safety of a preparation containing an antibiotic and an anti-inflammatory agent for acn…
-
FDA approval · 2006-05-11FDA Approved: CLARAVIS — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for CLARAVIS (isotretinoin) by Teva Pharmaceuticals USA, Inc.